CAS: 127134-13-8 - DABCYL-GAMMA-ABU-SER-GLN-ASN-TYR-PRO-ILE-VAL-GLN-EDANS
Formel:C73H97N17O18S
- Synonyme:
- 4-(4-Dimethylaminophenylazo)Benzoyl-Gamma-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-5-[(2-Aminoethyl)Amino]-Naphthalene-1-Sulfonic Acid
- Hiv Protease Fret Substrate I
- Dabcyl-Gaba-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Edans
DABCYL-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS
CAS:127134-13-8
The fluorogenic HIV-1 protease substrate DABCYL-Gaba-SQNYPIVQ-EDANS consists of an octapeptide with a fluorescent donor (EDANS) …
Formel:
C73H97N17O18S
Reinheit:
> 95%
Molekulargewicht:
1532.74
Ref: 01-4030716
1mg | 321,00 € | ||
5mg | 1.231,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 12. November 2024
L-Glutamamide, N-[4-[[4-[[4-(dimethylamino)phenyl]azo]benzoyl]amino]-1-oxobutyl]-L-seryl-L-glutaminyl-L-asparaginyl-L-tyrosyl-L-prolyl-L-isoleucyl-L-valyl-N1-[2-[(5-sulfo-1-naphthalenyl)amino]ethyl]- (9CI)
CAS:127134-13-8
Formel:
C73H97N17O18S
Molekulargewicht:
1532.7194
Ref: IN-DA000WPO
Unbestimmte Größe | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 15. November 2024
Dabcyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Edans
CAS:127134-13-8
Dabcyl-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Edans is a bifunctional peptide that inhibits HIV protease. The peptide binds to the active …
Formel:
C73H97N17O18S
Reinheit:
Min. 95%
Molekulargewicht:
1,532.75 g/mol
Ref: 3D-SFQ-3763-PI
1mg | 475,00 € | ||
5mg | 1.515,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 26. November 2024
DABCYL-gamma-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS trifluoroacetate salt
CAS:127134-13-8
Please enquire for more information about DABCYL-gamma-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS trifluoroacetate salt including the price, delivery time and …
Formel:
C73H97N17O18S
Reinheit:
Min. 95%
Molekulargewicht:
1,532.72 g/mol
Ref: 3D-FD110893
1mg | 669,00 € | ||
2mg | 1.050,00 € | ||
5mg | 2.249,00 € | ||
250µg | 268,00 € | ||
500µg | 430,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 10. Januar 2025